Theracryf Plc (TCF.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -61 | -58 | 7 | -4 | -47 |
| Other Working Capital | -96 | 241 | -118 | 194 | 57 |
| Other Operating Activity | -2,419 | -2,470 | -2,230 | -3,381 | -1,570 |
| Operating Cash Flow | $-2,576 | $-2,287 | $-2,341 | $-3,191 | $-1,560 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | 0 | -7 | -8 | -6 |
| Purchase Of Investment | N/A | N/A | N/A | 0 | -2,006 |
| Sale Of Investment | N/A | N/A | 0 | 2,006 | N/A |
| Purchase Sale Intangibles | N/A | N/A | 0 | -68 | -36 |
| Investing Cash Flow | $-1 | $0 | $-7 | $1,930 | $-2,048 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,003 | 761 | 2,333 | 0 | 9,014 |
| Other Financing Activity | -328 | -67 | -218 | 0 | -449 |
| Financing Cash Flow | $4,675 | $694 | $2,115 | $0 | $8,565 |
| Beginning Cash Position | 2,033 | 3,626 | 3,859 | 5,120 | 163 |
| End Cash Position | 4,131 | 2,033 | 3,626 | 3,859 | 5,120 |
| Net Cash Flow | $2,098 | $-1,593 | $-233 | $-1,261 | $4,957 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,576 | -2,287 | -2,341 | -3,191 | -1,560 |
| Capital Expenditure | -1 | N/A | -7 | -76 | -42 |
| Free Cash Flow | -2,577 | -2,287 | -2,348 | -3,267 | -1,602 |